RARA and acute myeloid leukemia: Therefore, we hypothesize that LDHB is involved in AML progression via regulating cell metabolism pathways and investigate the underlying mechanisms by which ATPR show the antileukaemic effects via the RARα/LDHB/ERK‐glycolysis signalling axis.